Sony forms genome analysis company in move towards personalized medicine
Sony is forming a new company to focus on genome research with a view towards realizing personalized medicine and healthcare. The venture, currently called P5 Inc, is a collaboration with M3, a medical company in which Sony is the majority stakeholder, and Illumina, a US-based manufacturer of …
Gio Salvador flipped this story into Tech Invest•3718d